Klinic Raises $24M Series A for Specialty Care Infrastructure

Klinic has raised $24M in Series A funding to expand provider-enablement infrastructure for independent specialty healthcare practices across the United States. The Frisco, Texas company is focused on a less glamorous but deeply consequential healthcare problem: making specialty care easier to deliver before administration, disconnected systems, and reimbursement friction slow patient access.

Founded by Avish Bhama, CEO, and Dan Cheung, Klinic supports providers with software and operating infrastructure across patient acquisition, intake, EHR, CRM, care coordination, revenue cycle management, billing, and prior authorization. The company says its platform has served more than 100,000 patients, works with more than 200 board-certified clinicians, and operates across all 50 states through Klinic Medical, PLLC.

That makes the financing more than another digital health funding headline. Klinic is betting that specialty medicine needs better delivery rails as much as it needs better treatments, and investors appear to be backing the operating layer that helps independent practices stay independent while scaling access.

What Happened

Klinic's $24M Series A gives the company more capital to expand its provider-enablement platform for independent specialty practices. The round was reported by HLTH on June 9, 2026, with Behavioral Health Business also covering the financing during the same announcement period.

The company's disclosed investor base includes Proofpoint Capital, I2BF Ventures, Draper Associates, Liquid 2 Ventures, Wicklow Capital, Dx Angels, Tau Ventures, Ross Lipson, Upstream Ventures, SeedtoB Capital, Sudo Labs, and Alan Keating. Public sources conflict on whether a single investor led the Series A, so the safer interpretation is that Klinic raised the round from a syndicate of venture and angel investors rather than assigning a lead investor without clear confirmation.

Why This Matters

Healthcare technology has spent years chasing patient engagement, virtual care, diagnostics, and AI-assisted workflows. Those categories still matter, but Klinic is working on the operational layer underneath them: the machinery that determines whether specialty providers can actually bring care to patients without drowning in back-office work.

Specialty care is where administrative complexity becomes especially expensive. A provider may need intake, scheduling, insurance verification, clinical documentation, pharmacy coordination, prior authorization, compliance controls, and revenue cycle support before the patient experience ever feels simple. Klinic packages those functions into a single operating environment so practices can spend more time treating patients and less time managing scattered systems.

Market Context

Provider enablement has become one of healthcare technology's quieter but more important categories. Independent specialists are dealing with heavier demand across behavioral health, psychiatry, oncology, cardiology, neurology, obesity care, and rare disease treatment while also facing more complicated payer, pharmacy, and compliance workflows.

Klinic's pitch fits that market pressure. The company is not trying to replace independent practices with a single branded care destination. It is trying to give those practices the infrastructure to launch, operate, and grow with fewer operational gaps. That distinction matters because specialty care depends on trust, clinician expertise, and recurring coordination across many participants.

Competitive Landscape

Healthcare infrastructure rarely gets the same attention as new therapeutics or AI models, but it increasingly determines whether medical innovation reaches patients. The most valuable platforms may be the ones that make existing providers faster, more compliant, and easier to access rather than the ones that ask providers to rebuild their entire model around another application.

Klinic sits in that practical layer of the market. Its model combines technology with practice operations, which can create a stronger moat than software alone when the customer problem spans patient demand, provider workflows, payer requirements, billing, and regulatory controls simultaneously.

What This Signals

The $24M Series A points to a larger investment theme inside healthcare technology. Investors are looking beyond single-point digital health tools and toward infrastructure companies that remove friction across the full delivery chain, especially in specialties where patient need is high and operational burden is heavy.

The breadth of the investor group, including Draper Associates and Liquid 2 Ventures, reinforces that interest in provider-enablement infrastructure rather than another standalone healthcare application.

For founders and operators, the lesson extends beyond healthcare. Markets continue rewarding companies that simplify critical workflows without forcing every existing participant to start over from scratch. Klinic's bet is that specialty care can scale when the operating system behind the practice gets stronger, and that may be one of the more durable places for healthcare venture capital to move next.